Literature DB >> 7441751

Development of antisickling compounds that chemically modify hemoglobin S specifically within the 2,3-diphosphoglycerate binding site.

J A Walder, R Y Walder, A Arnone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7441751     DOI： 10.1016/0022-2836(80)90385-x

Source DB:  PubMed          Journal:  J Mol Biol        ISSN： 0022-2836            Impact factor:   5.469


× No keyword cloud information.
  5 in total

1.  X-ray diffraction study of the binding of the antisickling agent 12C79 to human hemoglobin.

Authors:  F C Wireko; D J Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  Combining the influence of two low O2 affinity-inducing chemical modifications of the central cavity of hemoglobin.

Authors:  Parimala Nacharaju; Joel M Friedman; Muthuchidambaram Prabhakaran; Seetharama A Acharya; Belur N Manjula
Journal:  Biochemistry       Date:  2007-03-24       Impact factor: 3.162

3.  HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute.

Authors:  S R Snyder; E V Welty; R Y Walder; L A Williams; J A Walder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Hemoglobin tetramers stabilized by a single intramolecular cross-link.

Authors:  R E Benesch; S Kwong
Journal:  J Protein Chem       Date:  1991-10

5.  Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling.

Authors:  Akito Nakagawa; Francine E Lui; Dina Wassaf; Revital Yefidoff-Freedman; Dominick Casalena; Michelle A Palmer; Jacqueline Meadows; Andrea Mozzarelli; Luca Ronda; Osheiza Abdulmalik; Kenneth D Bloch; Martin K Safo; Warren M Zapol
Journal:  ACS Chem Biol       Date:  2014-08-11       Impact factor: 5.100
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.